Confirmed Control Closed Transaction verified Beautyclinical skincareCPGSkin Care

Obagi acquired by Waldencast

Waldencast acquired Obagi, a skincare brand.

Transaction summary

Target
Obagi
Acquirer
Waldencast
Seller
-
Announced
2021-11-15
Geography
-
Type
Acquisition
Deal type
Control
Stake acquired
-
First added
2026-06-18
Latest update
2026-10-21

Value and multiples

100% enterprise value

EUR 756M

100% enterprise value | EUR

Basis: FundComb estimate

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

Approx. $865M USD using FX date 2021-11-15 at 1.1444 EUR/USD.

EV / revenue

4.5x

Period not stated

Basis: FundComb estimate

EV / EBITDA

17.2x

EBITDA basis not stated

Basis: FundComb estimate

Basis

  • FundComb’s comps spreadsheet values Obagi at EUR 756m, used as the whole-company enterprise value; the spreadsheet attributes the figure to Rothschild. With revenue of EUR 168m and EBITDA of EUR 44m it gives 4.5x revenue and 17.2x EBITDA; the period is not stated. These are FundComb estimates, not confirmed by a public source. Waldencast announced a USD 1.2bn three-way business combination with Obagi and Milk Makeup in November 2021 (Business Wire); that figure covers both businesses, not Obagi alone.

Source summary

Waldencast Announces $1.2 Billion Three-Way Business Combination with Obagi and Milk Makeup as a First Step in its Strategy to Create a Global Multi-Brand Beauty and Wellness Platform - Business Wire

Confirmed
Open via Google News

Continue your research

Explore more comps →